Custom Lucite tombstone, incorporating a custom pewter brain, marking the initial public offering of NLS Pharmaceutics. The Swiss pharmaceutical firm specializes in therapies for complex central nervous system disorders. (21LJW052)
Custom Lucite tombstone, incorporating a custom pewter brain, marking the initial public offering of NLS Pharmaceutics. The Swiss pharmaceutical firm specializes in therapies for complex central nervous system disorders. (21LJW052)
Top view of Lucite financial tombstone showing custom pewter brain embedment.